2 results
Approved WMOCompleted
Primary: To estimate the MTD or RDE and preferred dosing schedule of LJM716 when administered in combination with trastuzumab in patients with HER2 overexpressing metastatic breast cancer or gastric cancer.Secondary: Safety and tolerability, PK, PD…
Approved WMORecruiting
To demonstrate the safety and efficacy of the SELUTION SLR* 014 DEB for treatment of bare-metal or drug-eluting in-stent restenosis (ISR).